It takes two to tango. Setting out the conditions in which performance-based risk-sharing arrangements work for both parties.

Faster regulatory approval processes often fail to achieve faster patient access. We seek an approach, using performance-based risk-sharing arrangements (PBRSA), to address uncertainty for payers regarding the relative effectiveness and value for money of products launched through accelerated approval schemes.One important reason for risk-sharing is to resolve differences of opinion between innovators and payers about a technology ’s underlying value. To date, there has been no formal attempt to set out the circumstances in which risk-sharing can address these differences.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research